This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

Professionals 248 Users Online

Balloon Infusers Market

Growing adoption of balloon infusers for their application in varied fluid drug delivery systems globally is boosting the market for balloon infusers

Balloon Infusers Market Segmented By Continuous Rate, Variable Rate Balloon Infusers Product

Balloon Infusers Market Outlook (2023-2033)

Worldwide revenue from the balloon infusers market stands at US$ 1.0 Bn in 2022, with the global market estimated to surge ahead at a CAGR value of 9.3% to reach a valuation of US$ 2.7 Bn by the end of 2033.

Balloon Infusers Market Size (2022)

US$ 1.0 Bn

Projected Market Value (2033)

US$ 2.7 Bn

Global Market Growth Rate (2023-2033)

9.3% CAGR

Market Share of Top 5 Countries

66.1%

As assessed by Persistence Market Research, balloon infusers products are expected to hold a market value of US$ 2.7 Bn by 2033. Overall, balloon infusers market sales account for approximately 14.9% of revenue share in the global pain management market, which was valued at around US$ 7.0 Bn in 2022.

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Sales Analysis of Balloon Infusers from 2016 to 2022 Vs Market Outlook for 2023 to 2033

The global market for balloon infusers recorded a historic CAGR of 6.5% in the last 6 years from 2016 to 2022.

Balloon infusers are used in the medical field to administer fluids; it can be either continuous or variable. Ambulatory disposable infusion pumps with a consistent drug flow rate throughout the infusion therapy session are known as continuous-rate elastomeric pumps and variable-rate elastomeric pumps have a variable rate controller, they are ambulatory disposable infusion pumps with variable drug flow. As a result, the flow of drugs can be controlled with the aid of a bolus in accordance with the patient's specific needs for pain relief and a bolus device that enables breakthrough pain relief on demand by the patient or healthcare provider.

The growing number of cancer cases are also a driving factor in the market of balloon infusion. For instance,

  • According to the National Cancer Institute, in the United States, the new cases of disease is projected to increases to 23.6 million by 2030.

Hospitals are required to provide medical care due to the rise in cancer cases and other chronic illnesses. In the coming years, it is anticipated that the growing number of hospital patients who require drug administration and surgical procedures through infusion will be the primary factor driving the growth of the global balloon infusers market.

Other than this one of the main factors driving demand for various types of balloon infusers over the past few years is growth in the estimates for surgical and non-surgical ambulatory operations being performed in hospitals and ambulatory surgery centres. Analgesics are typically infused using infusion pumps to manage post-operative pain following medical procedures such as hip and knee replacement. Therefore, it is anticipated that increasing orthopaedic surgeries and procedures will spur market growth over the upcoming years. For instance,

  • As per the 2018 Annual Report of American Academy of Orthopaedic Surgeons, more than 1 million patients and more than 1.4 million knee and hip arthroplasty surgeries were registered into the American Joint Replacement Registry.

The global balloon infusers market is thus likely to show high growth over the coming years a CAGR value of 9.3% and reach a global market size of around US$ 2.7 Bn by 2033.

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

How Can Balloon Infusers Manufacturers Grow?

Increased Adoption and Usage of Balloon Infusers in Several Aspects

The use of balloon infusers in portable regional anaesthesia is possible. According to numerous studies, the use of this device following shoulder surgery enables early and safe discharge of patients with less need for analgesics. Additionally, the growing use of these pumps in portable regional anaesthesia in cancer treatment facilities, dental clinics, and ambulatory care facilities globally is anticipated to offer considerable growth prospects for major players.

It is anticipated that chances for market growth will improve from the increased number of medical operations performed in hospitals as a result of the rise in accidents and chronic diseases. In instances like chemotherapy, efficient medication delivery systems are being required. Additionally, as research and development activities increase, more balloon infusers are produced, which are then employed widely for a variety of functions. It is anticipated that this will result in market growth. Moreover, balloon infusers are available in different types like the disposable, lightweight, and small sizes. Thus such advantages of balloon infusers over traditional electric infusion pumps are anticipated to create lucrative opportunities for the market.

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Can Demand for Balloon Infusers Market Be Affected in Any Way?

Increased Cost and Strict Regulatory Guidelines Could Affect the Growth of the Market

A significant barrier to the growth of the balloon infusers industry is the high and unstable cost of these devices. For instance, the price of infusers that deliver antibiotics is incredibly low, but the price of balloon infusers that deliver painkillers is substantially more and ranges from US$ 160 to US$ 450. During the anticipated years, this circumstance is anticipated to impede the growth of the global market.

The FDA also has strict requirements. Due to difficulties in the regulatory environment, investors in the sector are moving their money elsewhere, which restricts the growth of the market. Without more predictability from the FDA, new product introduction is challenging for both small and large device makers. Strict regulatory oversight on the use of plastics in balloon infusers is anticipated to impede market growth. For instance,

  • A safety assessment of medical devices with plasticized polyvinylchloride (PVC) and Di (2-ethylhexyl) phthalate (DEHP) in portions of balloon infusers was published by the U.S. FDA and the European Commission.

Therefore, producers must focus on providing products with adequate safety labels in order to avoid major adverse effects, especially in neonatal patients.

Thus the above-mentioned factors are a restrain that could have a negative impact on the market.

Prerna Shiv

Prerna Shiv
Client Partner

Let's Connect

Conect me to identify wining opportunities

Ask An Expert
I'm Available

Country-wise Insights

Why is the U.S. Balloon Infusers Market Booming?

“Increasing Cases of Chronic Diseases in the U.S.”

The U.S. accounted for around 89.3% market share in the North American market in 2022, and a similar trend is expected over the forecast period.

The market in U.S. is increasing with the growing number of chronic diseases. According to a research released in September 2020 by the Centres for Disease Control and Prevention, heart disease claims the lives of one American every 36 seconds and is the leading cause of death for both men and women across the majority of racial and ethnic groups in the country. Additionally, it is projected that the growing amount of research and development into new applications for balloon infusers will accelerate market growth.

Thus, with the above-mentioned factors, there will be continuous growth in the U.S. market in the forecast period as well.

Will Germany Be a Lucrative Market for Balloon Infusers?

“Increasing Number of Pharmaceutical and Biotechnology Companies in the Country”

Germany held around 27.5% market share of the Europe market in 2022.

Due to the presence of numerous biotechnology and pharmaceutical businesses, Germany is one of the top nations in the balloon infusers market. Rising government support for improving healthcare infrastructure is anticipated to accelerate market expansion. Additionally, the rise in the number of geriatrics and chronic conditions like diabetes, cardiovascular disease, and others will fuel market expansion in the nation.

Thus there is higher potential of increased usage of balloon infusers in the upcoming years as well.

How is India Emerging as a Prominent Market for Balloon Infusers?

“Increase Awareness of Balloon Infusers and the Increasing Number of Hospitals in the Country”

India held a market share of about 60.5% of the South Asia market in 2022.

The market is expanding due to a number of factors, including an increase in the number of hospitals with advanced medical facilities, healthcare reforms, the development of the R&D sector, and a rise in patient awareness of the benefits of balloon infusers with infusion pump technological advancements. Additionally, the market will expand as a result of rising demand for balloon infusers and increased population base incomes.

Thus India is a growing market and is expected to show potential growth in the forecast period.

Category-wise Insights

Which Product is Driving Growth of the Global Market?

“High Demand for Continuous Rate Elastomeric Pumps across Regions”

The continuous rate elastomeric pumps segment held around 67.8% share of the total market in 2022.

It is because of the increased applications and growing adoption of the continuous rate elastomeric pumps.

Continuous elastomeric pumps are best used throughout multiple chemotherapy infusions because they help maintain the therapeutic level of drugs during the treatment. Over the forecast period, market growth is anticipated to be fuelled by the rising incidence of cancer worldwide.

Which Application Drives Demand the Most for the Balloon Infusers Market?

“Pain Management is Increasing the Demand for Balloon Infusers”

Pain Management held the largest market share for the application segment at around 44.5% in 2022.

The growth in the number of surgeries like complete hip and knee replacements, which cause pain and necessitate quick pain relief, is helping the pain management industry. The volume of orthopedic operations and surgeries has increased quickly. These operations result in severe postoperative pain. As a result, anesthesia is used as an effective method of pain management following surgery or an operation. Over the course of the forecast period, the market is anticipated to grow significantly as a result of the increasing use of medications for controlling and reducing pain.

Which End User Settings Pose a Greater Adoption of Balloon Infusers?

“Growing Patient Pool in Hospitals”

Hospitals held a larger share of about 40.3% in 2022 globally.

Hospitals globally have the highest patient pool compared to the other end users. The usage of balloon infusers is also higher in several departments of hospitals including oncology, orthopedics, pain management, etc. Since currently, the use of balloon infusers is widely recommended by healthcare professionals, the usage is more in hospitals

Thus taking these factors into consideration, it is observed that hospitals hold the highest market share as end-users in the market.

Competitive Landscape

To improve their product lines across the globe, the leading manufacturers are developing technologically advanced products. The major competitors in the balloon infusers industry are involved in several consolidation activities such as product launches and mergers and acquisitions.

For instance:

  • In January 2021, Smiths Medical announced the launch of its EchoGlo® peripheral nerve block portfolio. This addition to the Portex® portfolio of pain management products offers customers a complete solution for regional anesthesia from the pump to patient.
  • In November 2020, Baxter International Inc. announced a $50 million expansion of its sterile fill/finish manufacturing facilities located in Bloomington, Ind. These facilities are operated by Baxter’s BioPharma Solutions business, a premier contract manufacturing organization that specializes in parenteral (injectable) pharmaceuticals.

Balloon Infusers Industry Report Scope

Attribute

Details

Forecast Period

2023-2033

Historical Data Available for

2016-2022

Market Analysis

USD Million for Value

Key Countries Covered

  • U.S.
  • Canada
  • Mexico
  • Brazil
  • Argentina
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • BENELUX
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Malaysia
  • Thailand
  • Australia
  • New Zealand
  • GCC Countries
  • Turkey
  • South Africa
  • North Africa

Key Market Segments Covered

  • Products
  • Application
  • End-User
  • Region

Key Companies Profiled

  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Baxter International Inc.
  • Terumo Corporation
  • Nipro Corporation
  • Smiths Medical
  • Avanos Medical, Inc.
  • Ambu A/S
  • Pfm Medical Ag
  • Daiken Medical Co., Ltd.
  • Palex Medical SA
  • Canack Technology Ltd.
  • PROMECON GmbH.
  • Halomedical Systems Ltd.

Report Coverage

  • Market Forecast
  • Competition Intelligence
  • DROT Analysis
  • Market Dynamics and Challenges
  • Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Key Segments Covered in Balloon Infusers Industry Research

By Product:

  • Continuous Rate Elastomeric Pumps
  • Variable Rate Elastomeric Pumps

By Application:

  • Pain Management
  • Antibiotic Therapy
  • Antiviral Therapy
  • Chemotherapy
  • Others

By End User:

  • Hospitals
  • Ambulatory Surgical Centres
  • Home Care Settings
  • Speciality Clinics
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

- Companies Covered in This Report -

  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Baxter International Inc.
  • Terumo Corporation
  • Nipro Corporation
  • Smiths Medical
  • Avanos Medical, Inc.
  • Ambu A/S
  • Pfm Medical Ag
  • Daiken Medical Co., Ltd.
  • Palex Medical SA
  • Canack Technology Ltd.
  • PROMECON GmbH.
  • Halomedical Systems Ltd.

- Frequently Asked Questions -

The global market is currently valued at around US$ 1.0 Bn in 2022.

Sales of the market are set to witness a high growth rate of 9.3% and be valued at US$ 2.7 Bn by 2033.

Demand for balloon infusers increased at 6.5% CAGR from 2016 to 2022.

The U.S., China, Germany, France and Japan account for most demand for balloon infusers, currently holding 66.1% market share.

The U.S. accounts for around 89.3% share of the North American market.

Baxter International Inc., B. Braun Melsungen AG and Fresenius Kabi AG are the top three manufacturers of balloon infusers.

Germany held around 27.5% market share of the Europe market in 2022.

Pain management has the highest market share of about 44.5% in 2022 among the other techniques.

Continuous Rate Elastomeric Pumps held the highest market share of about 67.8% in 2022, in the global market.

India held a market share of about 60.5% of the South Asia market in 2022.

Google translate